ID

36268

Description

Phase I, Dose Escalation Study of Decitabine; ODM derived from: https://clinicaltrials.gov/show/NCT02264873

Lien

https://clinicaltrials.gov/show/NCT02264873

Mots-clés

Versions (1)
  1. 27/04/2019 27/04/2019 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

27 avril 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Leukemia, Lymphoblastic, Acute NCT02264873

Anglais

Eligibility Leukemia, Lymphoblastic, Acute NCT02264873

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
age: greater than 1 and less than 31 years of age;
Description

Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
diagnosis: history of all, aml or mds, currently in a complete remission (cr) following allo-hsct (bone marrow leukemic blasts less than 5% by morphology), with high risk features including:
Description

Acute lymphocytic leukemia | Leukemia, Myelocytic, Acute | MYELODYSPLASTIC SYNDROME | In complete remission Following Allogeneic Hematopoietic Stem Cell Transplantation | Bone Marrow Leukemic Blast Count | Feature High risk

Type de données

boolean

Alias
UMLS CUI [1]
C0023449
UMLS CUI [2]
C0023467
UMLS CUI [3]
C3463824
UMLS CUI [4,1]
C0677874
UMLS CUI [4,2]
C0332282
UMLS CUI [4,3]
C1705576
UMLS CUI [5,1]
C0005953
UMLS CUI [5,2]
C2697913
UMLS CUI [6,1]
C2348519
UMLS CUI [6,2]
C4319571
status post allogeneic hsct
Description

Status post Allogeneic Hematopoietic Stem Cell Transplantation

Type de données

boolean

Alias
UMLS CUI [1,1]
C0231290
UMLS CUI [1,2]
C1705576
gvhd prophylaxis:
Description

Prophylaxis against graft versus host disease

Type de données

boolean

Alias
UMLS CUI [1]
C1096407
karnofsky or lansky performance scores more than 50%. karnofsky scores will be used for patients > 16 years of age and lansky scores for patients ≤ 16 years of age;
Description

Karnofsky Performance Status | Lansky Play-Performance Status | Age

Type de données

boolean

Alias
UMLS CUI [1]
C0206065
UMLS CUI [2]
C1522275
UMLS CUI [3]
C0001779
platelet count ≥ 50,000 (untransfused);
Description

Platelet Count measurement | Transfusion Absent

Type de données

boolean

Alias
UMLS CUI [1]
C0032181
UMLS CUI [2,1]
C1879316
UMLS CUI [2,2]
C0332197
absolute neutrophil count ≥ 1000; and;
Description

Absolute neutrophil count

Type de données

boolean

Alias
UMLS CUI [1]
C0948762
hemoglobin ≥ 8 g/dl (un-transfused);
Description

Hemoglobin measurement | Transfusion Absent

Type de données

boolean

Alias
UMLS CUI [1]
C0518015
UMLS CUI [2,1]
C1879316
UMLS CUI [2,2]
C0332197
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
progressive disease;
Description

Progressive Disease

Type de données

boolean

Alias
UMLS CUI [1]
C1335499
philadelphia chromosome positive all (these patients receive tyrosine kinase inhibitor posttransplant);
Description

Philadelphia positive acute lymphocytic leukaemia | Tyrosine kinase inhibitor therapy Post Transplantation

Type de données

boolean

Alias
UMLS CUI [1]
C4524071
UMLS CUI [2,1]
C0879484
UMLS CUI [2,2]
C0687676
UMLS CUI [2,3]
C0040732
known hypersensitivity to any components of decitabine;
Description

Hypersensitivity Decitabine Component

Type de données

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0049065
UMLS CUI [1,3]
C1705248
uncontrolled grade 3-4 graft versus host disease;
Description

Graft-vs-Host Disease Grade Uncontrolled

Type de données

boolean

Alias
UMLS CUI [1,1]
C0018133
UMLS CUI [1,2]
C0441800
UMLS CUI [1,3]
C0205318
uncontrolled infection;
Description

Communicable Disease Uncontrolled

Type de données

boolean

Alias
UMLS CUI [1,1]
C0009450
UMLS CUI [1,2]
C0205318
serum creatinine > 2 mg/dl or glomerular filtration rate (gfr) less than 60 ml/min/1.73m2 ;
Description

Creatinine measurement, serum | Glomerular Filtration Rate

Type de données

boolean

Alias
UMLS CUI [1]
C0201976
UMLS CUI [2]
C0017654
alanine aminotransferase (alt) greater than 3 times normal or serum total bilirubin greater than 2 mg/dl;
Description

Alanine aminotransferase increased | Serum total bilirubin measurement

Type de données

boolean

Alias
UMLS CUI [1]
C0151905
UMLS CUI [2]
C1278039
Retour au début de la page

Similar models

Eligibility Leukemia, Lymphoblastic, Acute NCT02264873

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
age: greater than 1 and less than 31 years of age;
boolean
C0001779 (UMLS CUI [1])
Acute lymphocytic leukemia | Leukemia, Myelocytic, Acute | MYELODYSPLASTIC SYNDROME | In complete remission Following Allogeneic Hematopoietic Stem Cell Transplantation | Bone Marrow Leukemic Blast Count | Feature High risk
Item
diagnosis: history of all, aml or mds, currently in a complete remission (cr) following allo-hsct (bone marrow leukemic blasts less than 5% by morphology), with high risk features including:
boolean
C0023449 (UMLS CUI [1])
C0023467 (UMLS CUI [2])
C3463824 (UMLS CUI [3])
C0677874 (UMLS CUI [4,1])
C0332282 (UMLS CUI [4,2])
C1705576 (UMLS CUI [4,3])
C0005953 (UMLS CUI [5,1])
C2697913 (UMLS CUI [5,2])
C2348519 (UMLS CUI [6,1])
C4319571 (UMLS CUI [6,2])
Status post Allogeneic Hematopoietic Stem Cell Transplantation
Item
status post allogeneic hsct
boolean
C0231290 (UMLS CUI [1,1])
C1705576 (UMLS CUI [1,2])
Prophylaxis against graft versus host disease
Item
gvhd prophylaxis:
boolean
C1096407 (UMLS CUI [1])
Karnofsky Performance Status | Lansky Play-Performance Status | Age
Item
karnofsky or lansky performance scores more than 50%. karnofsky scores will be used for patients > 16 years of age and lansky scores for patients ≤ 16 years of age;
boolean
C0206065 (UMLS CUI [1])
C1522275 (UMLS CUI [2])
C0001779 (UMLS CUI [3])
Platelet Count measurement | Transfusion Absent
Item
platelet count ≥ 50,000 (untransfused);
boolean
C0032181 (UMLS CUI [1])
C1879316 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Absolute neutrophil count
Item
absolute neutrophil count ≥ 1000; and;
boolean
C0948762 (UMLS CUI [1])
Hemoglobin measurement | Transfusion Absent
Item
hemoglobin ≥ 8 g/dl (un-transfused);
boolean
C0518015 (UMLS CUI [1])
C1879316 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Item Group
C0680251 (UMLS CUI)
Progressive Disease
Item
progressive disease;
boolean
C1335499 (UMLS CUI [1])
Philadelphia positive acute lymphocytic leukaemia | Tyrosine kinase inhibitor therapy Post Transplantation
Item
philadelphia chromosome positive all (these patients receive tyrosine kinase inhibitor posttransplant);
boolean
C4524071 (UMLS CUI [1])
C0879484 (UMLS CUI [2,1])
C0687676 (UMLS CUI [2,2])
C0040732 (UMLS CUI [2,3])
Hypersensitivity Decitabine Component
Item
known hypersensitivity to any components of decitabine;
boolean
C0020517 (UMLS CUI [1,1])
C0049065 (UMLS CUI [1,2])
C1705248 (UMLS CUI [1,3])
Graft-vs-Host Disease Grade Uncontrolled
Item
uncontrolled grade 3-4 graft versus host disease;
boolean
C0018133 (UMLS CUI [1,1])
C0441800 (UMLS CUI [1,2])
C0205318 (UMLS CUI [1,3])
Communicable Disease Uncontrolled
Item
uncontrolled infection;
boolean
C0009450 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
Creatinine measurement, serum | Glomerular Filtration Rate
Item
serum creatinine > 2 mg/dl or glomerular filtration rate (gfr) less than 60 ml/min/1.73m2 ;
boolean
C0201976 (UMLS CUI [1])
C0017654 (UMLS CUI [2])
Alanine aminotransferase increased | Serum total bilirubin measurement
Item
alanine aminotransferase (alt) greater than 3 times normal or serum total bilirubin greater than 2 mg/dl;
boolean
C0151905 (UMLS CUI [1])
C1278039 (UMLS CUI [2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial